Evidence map›Paper›PMID 30335766›Full record

ArticlePloS one2018

HIV test uptake and related factors amongst heterosexual drug users in Shandong province, China.

Zhenxia Jiang, Cuizhen Xiu, Jun Yang, Xijiang Zhang, Minghua Liu, Xinlong Chen, Dianchang Liu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhenxia JiangDepartment of HIV/STI Prevention and Control, Qingdao Municipal Center for Disease Control and Prevention, Qingdao, Shandong, China.ORCID 0000-0002-0933-3624
Cuizhen XiuDepartment of HIV/STI Prevention and Control, Qingdao Municipal Center for Disease Control and Prevention, Qingdao, Shandong, China.
Jun YangDepartment of STI and Leprosy Prevention and Control, Jining Hospital for Skin Disease Control and Prevention, Jining, Shandong, China.
Xijiang ZhangDepartment of HIV/STI Prevention and Control, Qingdao Municipal Center for Disease Control and Prevention, Qingdao, Shandong, China.
Minghua LiuDepartment of HIV/STI Prevention and Control, Qingdao Municipal Center for Disease Control and Prevention, Qingdao, Shandong, China.
Xinlong ChenDepartment of STI and Leprosy Prevention and Control, Shandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China.
Dianchang LiuDepartment of STI and Leprosy Prevention and Control, Shandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China.
Qingdao Municipal Center for Disease Control and Prevention · CNShandong Provincial Institute of Dermatology and Venereology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn China, the mode of HIV transmission and the types and routes of drug use have changed in the past decade. HIV testing amongst drug users needs further improvement.

methodsInterviewer-administered questionnaires were used for data collection amongst 600 heterosexual drug users from the community and a municipal detention centre, where criminal suspects are supervised. Descriptive statistics, univariate analysis and multilevel logistic regression analysis were used to identify the factors associated with HIV testing amongst heterosexual drug users. All participants were screened HIV and sexually transmitted infections.

resultsAmongst 600 participants, 554 (92.3%) were methamphetamine users, and 155 (25.8%) underwent HIV testing in the past year. Multivariate analysis results revealed that drug users who were single (adjusted odds ratio(AOR) = 1.923, 95% confidence interval(CI) = 1.189-3.109), had less knowledge of HIV (AOR = 1.706, 95% CI = 1.074-2.711), used only one kind of drug (AOR = 2.649, 95% CI = 1.155-6.077), used drug via a non-injection route (AOR = 2.121, 95% CI = 1.103-4.078), did not receive free condoms (AOR = 2.307, 95% CI = 1.129-4.715) and who did not receive free publicity material from health workers in the past year (AOR = 2.828, 95% CI = 1.757-4.552) were less likely to undergo HIV testing. A total of 594 participants underwent HIV and syphilis screening in this survey. Amongst these participants, 2 (0.3%) were HIV antibody positive, and 88 (14.8%) showed positive results in both non-treponemal test (rapid plasma regain test) and treponemal test (Treponema pallidum particle agglutination test) for the first time.

conclusionsThe rate of HIV test uptake amongst heterosexual drug users in China remains low. Thus, more specific interventions are urgently needed to improve the utilisation of HIV testing amongst heterosexual drug users, particularly amongst non-injection drug users in China.

Indexed as

Amphetamine-Related DisordersDrug UsersHeterosexualityPatient Acceptance of Health CareAdolescentAdultChinaFemaleHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansMaleMiddle AgedYoung Adult

Identifiers

PMID30335766
PMCPMC6193625
OpenAlexW2896403815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.